A A A

Grants for all

Grants awarded to Cardiac Unit Staff 2009 to 2010

2010

Deanfield JE, Davey Smith G, Sattar N and Muthurangu V: British Heart Foundation. 'The impact of adiposity on risk profiles and the emerging arterial phenotype in the young.'
Deanfield JE, Giardini A and Martin J: National, Heart, Lung and Blood Institute, USA. ‘Genetic architecture of congenital heart disease.’
Deanfield JE, Klein N and Loukogeorgakis S: GOSH Charity. ' Venous endothelial cells in humans.'
Deanfield JE and Kuh D: Medical Research Council. 'Life course pathways to ageing: MRC National Survey of Health and Development
Dunger D, Tossavainen P, Marcovecchio L, Ong K, Parker RA and Deanfield JE: Diabetes UK. ' Familial aggregation of cardiovascular disease risk factors in parents of adolescents with type 1 diabetes and incipient nephropathy.'
Elliott MJ, Roebuck D, Birchall M, Burns S, Bitner-Glindzicz M and Vondrys D: GOSH Biomedical Research Centre. ‘Trial of biodegradable stents for treatment of tracheal stenosis and malacia in children.’
Elliott PM: EC Scientific Programme 'Co-operation' FP7 Framework. 'Integrated heart research in translational genetics of dilated cardiomyopathies in Europe (INHERITANCE).'
Taylor AM: Siemens Medical Solutions. 'Computational models for personalised therapy in paediatric cardiology.'
Tsang VT, Brown KL, Cunningham D, Pagel C, Gallivan S and Utley M: National Institute for Health Research. 'The application of a mortality risk model to adjust the case mix in paediatric cardiac surgery for the United Kingdom using the central cardiac audit database.'

2009

Burch M, Klein N, Simmonds JD and Griffiths PD: GOSH Charity. ‘The role of cytomegalovirus in the initiation and progress of cardiac allograft vasculopathy in children.’
Catchpole C, Goldman A and McQuillan A: BUPA. ‘Improving the safety and quality of hospital handovers to BUPA.’
Deanfield JE: CORDA and GOSH Charity. ‘Obesity and the onset of arterial disease in the young: mechanisms and potential for reversibility.’
Deanfield JE, D’Aiuto F and O’Neill F: Colgate. ‘HDL functionality in periodontitis.’
Deanfield JE, Kuh D, Hingorani A, Pellerin D, Whincup P, Friberg P and Hardy R: MRC. ‘Life course pathways to ageing: MRC national survey of health and development.’
Deanfield JE and O’Neill F: Roche. ‘HDL phenotype in rheumatoid and response to effective treatment.’
Elliott PM, Moon J and Taylor AM: Genzyme Therapeutics. ‘Identifying early changes in the hearts of individuals with Anderson-Fabry disease: New methods of measuring fibrosis and myocardial lipid.’
Goldman A and McQuillan A: National Patient Safety Agency. ‘Assessing briefing and debriefing in the Intensive Care Unit.’
Jones A, Muthurangu V, Deanfield JE and Taylor AM: ICH/GOSH Biomedical Research Centre. 'CIMES - The Cardiovascular Imaging during Mental Exertion Study.'
Klein N, Deanfield JE, Gibb D and Kenny J: Wellcome Trust. ‘The impact of HIV and antiretroviral therapy on the cardiovascular system in HIV-infected children.’
Riley P and Burch M: Medical Research Council and GOSH Charity. ‘Investigation the role of Prox1 in regulating cardiac and skeletal muscle gene programs during heart development and disease.’
Robertson N, Taylor AM, Thayyil S, Jacques T, Sebire N, Cook A, Yousry T, Lythgoe M and Elliott: UCLH/UCL CBRC ‘High field Post-mortem Magnetic Resonance Microscopy of fetal and neonatal brain and heart.’
Taylor AM, Hsia T-Y and Bonhoeffer P:  Leducq Foundation ‘Multi-Scale Modeling of Single Ventricle Hearts for Clinical Decision Support.’
Taylor AM, Muthurangu V and Atkinson D: Siemens Medical Solutions. ‘Development of magnetic resonance methods of fat quantification.’ 
Taylor AM and Odenwald T: Marie Curie Actions—Intra-European Fellowships. ‘Heart device imaging - Advancing percutaneous heart valve repair in children through the development of new cardiac imaging strategies.’
Taylor AM, Schievano S, Bonhoeffer P and Odenwald T: EC Marie Curie and NIHR.  ‘The development of imaging strategies to help in the design, the pre-and post-procedural assessment, and the deployment of percutaneous heart valve devices.’
Taylor AM and Schuler P: European Society of Cardiology (ESC). ‘Assessment of cardiovascular function during exercise using MR before and after PPVI.’

Page last modified on 28 jul 10 12:48